News
Immunai raises USD 215 million for its drug discovery platform
Immunai uses analytics and machine learning to improve the efficiency of immunotherapies, revealing insights that lead to the development of new therapy programs.
Content Partner • nocamels@kr-asia.com
News
Immunai uses analytics and machine learning to improve the efficiency of immunotherapies, revealing insights that lead to the development of new therapy programs.